Viewing Study NCT02573259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-01-31 @ 3:46 AM
Study NCT ID: NCT02573259
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2015-10-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Part 1 View
None MELANOMA View
None SCCHN View
None OVCA View
None SARCOMA View
None OTHER SOLID TUMORS View
None Part 1 and 2 View
None NSCLC View
None UROTHELIAL CARCINOMA View
Keywords:

Keywords

Keyword Brief Keyword Text View
None efficacy View
None safety View
None pharmacokinetics View
None pharmacodynamics View
None open label View
None dose response View
None multiple ascending dose View
None immunogenicity View
None recommended phase 2 dose View
None subcutaneous View